Home > Healthcare > Medical Devices > Implantable Devices > Coronary Artery Bypass Graft Market
Coronary Artery Bypass Graft Market Trends
- Report ID: GMI8564
- Published Date: Mar 2024
- Report Format: PDF
Coronary Artery Bypass Graft Market Trends
Technological advancements in CABG procedures have revolutionized the landscape of cardiovascular surgery, offering innovative solutions to address the complex challenges associated with coronary artery disease (CAD) and other cardiovascular conditions.
- These advancements include the adoption of minimally invasive techniques, such as robotic-assisted surgery and endoscopy, which are estimated to reach USD 72 billion by 2032. These approaches result in reduced trauma, shorter recovery times, and improved patient outcomes.
- Further, robotic medical imaging systems allow surgeons to perform CABG procedures with enhanced precision and dexterity. These systems provide a three-dimensional view of the surgical field, along with instruments that can rotate and bend with greater flexibility than the human hand.
- Moreover, innovations in imaging technologies, such as intraoperative angiography and three-dimensional imaging, enable surgeons to visualize coronary arteries and cardiac structures with exceptional detail during CABG procedures.
Frequently Asked Questions (FAQ) :
Coronary artery bypass graft (CABG) industry size reached USD 13.9 billion in 2023 and is poised to surpass USD 24.9 billion by 2032 owing to the increasing prevalence of cardiovascular diseases globally.
The minimally invasive direct segment is estimated to reach USD 16.8 billion by 2032 to help minimize surgical trauma and tissue damage while reducing blood loss for ultimately enhancing operational efficiency and optimizing patient outcomes.
North America held 40.5% revenue share of the coronary artery bypass graft market in 2023 and is set to exhibit robust growth through 2032 attributed to the rising innovation in cardiovascular medicine driving ongoing research efforts aimed at developing novel surgical techniques.
Leading companies operating in the coronary artery bypass graft industry are Edwards Lifesciences Corporation, Getinge AB, Genesee Biomedical, Guidant Corporation, LivaNova PLC, Medtronic plc, Novadaq Technologies Inc., Stryker Corporation, Teleflex Incorporated, and Terumo Corporation.
Coronary Artery Bypass Graft Market Scope
×
Get a free sample of
Coronary Artery Bypass Graft Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below